The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab.

Auteurs

Buisseret L, Bareche Y, Venet D, Girard E, Gombos A, Emonts P, Majjaj S, Rouas G, Serra M, Debien V, Agostinetto E, Garaud S, Willard-Gallo K, Larsimont D, Stagg J, Rothé F, Sotiriou C

  • Date de publication

    Mai 2024

  • Type

    Article

  • Revue

    ESMO Open

  • Nom du chercheur

    BUISSERET LAURENCE

  • Hôpital

    Institut Jules Bordet

  • Service

    Médecine Oncologique

  • PMID

    38703428

  • DOI

    10.1016/j.esmoop.2024.102964